HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review)

  • Authors:
    • Xiaoxia Wang
    • Meijuan Chen
    • Jing Zhou
    • Xu Zhang
  • View Affiliations

  • Published online on: April 25, 2014     https://doi.org/10.3892/ijo.2014.2399
  • Pages: 18-30
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Among the heat shock proteins (HSP), HSP27, HSP70 and HSP90 are the most studied stress-inducible HSPs, and are induced in response to a wide variety of physiological and environmental insults, thus allowing cells to survive to lethal conditions based on their powerful cytoprotective functions. Different functions of HSPs have been described to explain their cytoprotective functions, including their most basic role as molecular chaperones, that is to regulate protein folding, transport, translocation and assembly, especially helping in the refolding of misfolded proteins, as well as their anti-apoptotic properties. In cancer cells, the expression and/or activity of the three HSPs is abnormally high, and is associated with increased tumorigenicity, metastatic potential of cancer cells and resistance to chemotherapy. Associating with key apoptotic factors, they are powerful anti-apoptotic proteins, having the capacity to block the cell death process at different levels. Altogether, the properties suggest that HSP27, HSP70 and HSP90 are appropriate targets for modulating cell death pathways. In this review, we summarize the role of HSP90, HSP70 and HSP27 in apoptosis and the emerging strategies that have been developed for cancer therapy based on the inhibition of the three HSPs.
View Figures
View References

Related Articles

Journal Cover

July 2014
Volume 45 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Wang, X., Chen, M., Zhou, J., & Zhang, X. (2014). HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review). International Journal of Oncology, 45, 18-30. https://doi.org/10.3892/ijo.2014.2399
MLA
Wang, X., Chen, M., Zhou, J., Zhang, X."HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review)". International Journal of Oncology 45.1 (2014): 18-30.
Chicago
Wang, X., Chen, M., Zhou, J., Zhang, X."HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review)". International Journal of Oncology 45, no. 1 (2014): 18-30. https://doi.org/10.3892/ijo.2014.2399